Back to Search
Start Over
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study
- Source :
- Leukemia, 32(8), 1803-1807. Nature Publishing Group
- Publication Year :
- 2017
- Subjects :
- Oncology
medicine.medical_specialty
Cancer Research
Dexamethasone
Cohort Studies
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Hematology
Anesthesiology and Pain Medicine
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
Survival rate
Multiple myeloma
business.industry
Low dose
Follow-Up Studies
Multiple Myeloma
Oligopeptides
Prognosis
Survival Rate
Thalidomide
medicine.disease
Pomalidomide
Carfilzomib
chemistry
030220 oncology & carcinogenesis
Relapsed refractory
business
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 32
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi.dedup.....d78cb78f6d3a5917a37eca2f9e43f6af